Rank #1083CERS

Cerus Corporation

$2.56

3.64% (Daily)

Market Cap

$491.74M

Revenue

$199.19M

Rank by MCap

#1083

Sector

Healthcare

Industry

Medical Devices

CEO

Mr. William M. Greenman

Headquarters

Concord, CA

Employees

614

About Cerus Corporation

Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers INTERCEPT Blood Systems for platelets and plasma, which is designed to inactivate blood-borne pathogens in platelets...